Jane Street’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jane Street’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-133,819	Closed	-$7.02M	–	8534
2020 Q3	$7.02M	Buy	133,819 +119,192	+815%	+$4.93M	﹤0.01%	1520
2020 Q2	$487K	Buy	+14,627	New	+$466K	﹤0.01%	5123
2019 Q4	–	Sell	-17,137	Closed	-$222K	–	6085
2019 Q3	$222K	Buy	+17,137	New	+$207K	﹤0.01%	4541
2016 Q3	–	Sell	-10,058	Closed	-$109K	–	4739
2016 Q2	$109K	Buy	+10,058	New	+$104K	﹤0.01%	3884
2014 Q4	–	Sell	-13,701	Closed	-$155K	–	3228
2014 Q3	$155K	Buy	+13,701	New	+$156K	﹤0.01%	2285
2014 Q1	–	Sell	-11,205	Closed	-$198K	–	3204
2013 Q4	$198K	Buy	+11,205	New	+$188K	﹤0.01%	2035

Jane Street's MNTA Position: Q4 2020 in Review

Jane Street sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 133,819 shares — an estimated $7.02M sold.

Jane Street first reported a position in MNTA in Q4 2013 and held it in 6 quarters. The position peaked at $7.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Jane Street reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Jane Street sold 133,819 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.02M.
Jane Street first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 6 quarters.
Jane Street's Momenta Pharmaceuticals, Inc. position peaked at $7.02M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.